 |
1A1M |
MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2 |
C |
A |
MHC antigen-recognition domain |
|
 |
1A1N |
MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1 |
C |
A |
MHC antigen-recognition domain |
|
 |
1AGB |
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION) |
C |
A |
MHC antigen-recognition domain |
|
 |
1AGC |
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION) |
C |
A |
MHC antigen-recognition domain |
|
 |
1AGD |
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE) |
C |
A |
MHC antigen-recognition domain |
|
 |
1AGE |
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION) |
C |
A |
MHC antigen-recognition domain |
|
 |
1AGF |
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION) |
C |
A |
MHC antigen-recognition domain |
|
 |
1I1Y |
CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y |
C |
A |
MHC antigen-recognition domain |
|
 |
1S8D |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-3A |
C |
A |
MHC antigen-recognition domain |
|
 |
1T1W |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-3F6I8V |
C |
A |
MHC antigen-recognition domain |
|
 |
1T1X |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-4L |
C |
A |
MHC antigen-recognition domain |
|
 |
1T1Y |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-5V |
C |
A |
MHC antigen-recognition domain |
|
 |
1T1Z |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-6A |
C |
A |
MHC antigen-recognition domain |
|
 |
1T20 |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-6I |
C |
A |
MHC antigen-recognition domain |
|
 |
1T21 |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9, monoclinic crystal |
C |
A |
MHC antigen-recognition domain |
|
 |
1T22 |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9, orthorhombic crystal |
C |
A |
MHC antigen-recognition domain |
|
 |
2BSR |
CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 |
C |
A |
MHC antigen-recognition domain |
|
 |
2BST |
CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 |
C |
A |
MHC antigen-recognition domain |
|
 |
2C7U |
CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. |
C |
A |
MHC antigen-recognition domain |
|
 |
2HJK |
Crystal Structure of HLA-B5703 and HIV-1 peptide |
C |
A |
MHC antigen-recognition domain |
|
 |
2HJL |
Crystal Structure of HLA-B5703 and HIV-1 peptide |
C |
A |
MHC antigen-recognition domain |
|
 |
2V2W |
T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT |
C |
A |
MHC antigen-recognition domain |
|